en
Scientific article
English

Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda

Published inAnnals of tropical medicine and parasitology, vol. 102, no. 1, p. 11-19
Publication date2008
Abstract

Between September 2003 and April 2004, the supply of antimonial drugs to Amudat Hospital, in north-eastern Uganda, was interrupted and all cases of visceral leishmaniasis presenting at the hospital could only be treated with amphotericin B deoxycholate (AmB). This allowed the safety and effectiveness of the AmB to be evaluated, in comparison with an historical cohort of patients treated, at the same hospital, with meglumine antimoniate (Sb(V)). Demographic and clinical data were collected before and after treatment. Adverse effects were recorded passively in all the subjects, and actively, using a standardized questionnaire, in a sub-group of the patients given AmB. The in hospital case-fatality 'rates' were 4.8% [95% confidence interval (CI) = 2.4%-8.8%] among the 210 patients treated with AmB and 3.7% (CI = 1.4%-7.9%) among the 161 patients treated with Sb(V) (P>0.20). Adverse effects requiring treatment interruption were rare in both cohorts. Treatment failures (i.e. non-responses or relapses) were observed in 2.9% (CI = 1.2%-6.4%) of the patients treated with AmB and 1.2% (CI = 0.1%-4.4%) of the patients treated with Sb(V) (P>0.20). For the treatment of visceral leishmaniasis in Uganda, AmB therefore had a similar effectiveness and safety profile to that of meglumine antimoniate.

Keywords
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Amphotericin B/adverse effects
  • Animals
  • Antiprotozoal Agents/adverse effects
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • Humans
  • Infant
  • Kenya
  • Leishmania donovani/parasitology
  • Leishmaniasis, Visceral/drug therapy/epidemiology
  • Male
  • Meglumine/therapeutic use
  • Middle Aged
  • Organometallic Compounds/therapeutic use
  • Statistics as Topic
  • Treatment Outcome
  • Uganda
Citation (ISO format)
MUELLER, Y. et al. Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda. In: Annals of tropical medicine and parasitology, 2008, vol. 102, n° 1, p. 11–19. doi: 10.1179/136485908X252142
Main files (1)
Article (Accepted version)
accessLevelRestricted
Identifiers
ISSN of the journal0003-4983
532views
0downloads

Technical informations

Creation06/04/2009 10:10:00 AM
First validation06/04/2009 10:10:00 AM
Update time03/14/2023 3:06:12 PM
Status update03/14/2023 3:06:11 PM
Last indexation01/15/2024 6:31:44 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack